同源康医药-B盘中异动早盘大幅下挫5.38%_老虎社区_美港股上老虎

同源康医药-B盘中异动早盘大幅下挫5.38%

市场透视11-04

2024年11月04日早盘09时39分，同源康医药-B（02410.hk）股票出现波动，股价急速下挫5.38%。截至发稿，该股报22.000港元/股，成交量4000股，换手率0.00%，振幅1.29%。资金方面，该股资金流入4.6325万港元，流出3.445万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-19.33倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2480310451?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-04 09:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2480310451","market":"hk","top_or_hot":-1,"title":"同源康医药-B盘中异动 早盘大幅下挫5.38%","media":"市场透视","content":"<div>\n<p>2024年11月04日早盘09时39分，同源康医药-B（02410.hk）股票出现波动，股价急速下挫5.38%。截至发稿，该股报22.000港元/股，成交量4000股，换手率0.00%，振幅1.29%。资金方面，该股资金流入4.6325万港元，流出3.445万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-19.33倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093930971a402b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>同源康医药-B盘中异动 早盘大幅下挫5.38%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n同源康医药-B盘中异动 早盘大幅下挫5.38%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-04 09:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093930971a402b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024年11月04日早盘09时39分，同源康医药-B（02410.hk）股票出现波动，股价急速下挫5.38%。截至发稿，该股报22.000港元/股，成交量4000股，换手率0.00%，振幅1.29%。资金方面，该股资金流入4.6325万港元，流出3.445万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-19.33倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093930971a402b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093930971a402b&s=b","article_id":"2480310451","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093930971a402b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2480310451","pubTimestamp":1730684370,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2024年11月04日早盘09时39分，同源康医药-B股票出现波动，股价急速下挫5.38%。截至发稿，该股报22.000港元/股，成交量4000股，换手率0.00%，振幅1.29%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，昭衍新药、腾盛博药-B、云顶新耀-B涨幅较大，振幅较大的相关个股有方达控股、昭衍新药、科济药业-B，振幅分别为13.48%、9.16%、8.14%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1515":"抗疫概念","BK1161":"生物科技","BK1574":"生物医药B类股","09939":"开拓药业-B","02410":"同源康医药-B"},"translate_title":"Tongyuankang Pharmaceutical-B intraday changes fell sharply 5.38% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02410":1,"09939":1},"content_text":"2024年11月04日早盘09时39分，同源康医药-B（02410.hk）股票出现波动，股价急速下挫5.38%。截至发稿，该股报22.000港元/股，成交量4000股，换手率0.00%，振幅1.29%。资金方面，该股资金流入4.6325万港元，流出3.445万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-19.33倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，昭衍新药、腾盛博药-B、云顶新耀-B涨幅较大，振幅较大的相关个股有方达控股、昭衍新药、科济药业-B，振幅分别为13.48%、9.16%、8.14%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发,其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI,对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}